July 07, 2025 a 01:01 pm
UNH: Fundamental Ratio Analysis - UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified healthcare company in the U.S. The company has a substantial presence through segments such as UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. Overall, the stock shows moderate potential based on its current financial ratios.
Fundamentales Rating
Overall, UnitedHealth Group displays a satisfactory fundamental rating, supported by strong scores in critical metrics.
| Kategorie | Score | Visualisierung |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 5 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historisches Rating
Comparing current and previous scores illustrates the stock's performance over time.
| Datum | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-03 | 3 | 5 | 5 | 4 | 1 | 2 | 2 |
| 2025-07-07 | 0 | 5 | 5 | 4 | 1 | 2 | 2 |
Analysten-Kursziele
Market experts have set varied price targets, suggesting potential growth opportunities.
| Hoch | Tief | Median | Konsens |
|---|---|---|---|
| $575 | $270 | $367 | $382.38 |
Analystenstimmung
The prevailing sentiment among analysts reflects a bullish outlook for the stock.
| Empfehlung | Anzahl | Verteilung |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 40 | |
| Hold | 7 | |
| Sell | 3 | |
| Strong Sell | 0 |
Fazit
UnitedHealth Group Incorporated presents a moderately attractive investment opportunity with strong fundamentals in key areas such as discounted cash flow and return on equity. However, the high debt-to-equity ratio and moderate price-to-earnings suggest potential financial risks. Analyst consensus is bullish, with a buy recommendation prevailing. Investors should weigh the company's solid healthcare service offerings against market volatility. Overall, the stock could offer growth potential for a risk-tolerant portfolio.